Ample evidence has confirmed that FOXP3 is not only specifically expressed in Treg cells derived from the thymus or peripheral, but also abnormally expressed in a variety of tumor cells, and is closely related to the occurrence, development, and prognosis of tumors [32–36]. This evidence concerns the gene FOXP3 and neoplasm.